Chemo-immunotherapy of colorectal carcinoma : Preclinical rationale and clinical experience
Novel in vitro model barriers for evaluation of the permeability of antitumor compounds, thioxanthones
Phase I study of gefitinib, oxaliplatin, 5-fluorouracil, and leucovorin (IFOX) in patients with advanced solid malignancies
A Phase I Safety And Dose Escalation Trial Of Docetaxel Combined With GEM©231, A Second Generation Antisense Oligonucleotide Targeting Protein Kinase A R1α In Patients With Advanced Solid Cancers*
Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma
A randomized phase II trial of interleukin-2 in combination with four different doses of bryostatin-1 in patients with renal cell carcinoma
Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1) : West Japan Thoracic Oncology Group (WJTOG) trial
Phase II trial of DNA methyltransferase 1 inhibition with the antisense oligonucleotide MG98 in patients with metastatic renal carcinoma : A National Cancer Institute of Canada Clinical Trials Group investigational new drug study